loading...| Preferred Name |
Metaxalone |
|
| Synonyms |
2-Oxazolidinone, 5-((3,5-dimethylphenoxy)methyl)- METAXALONE Metaxalone Skelaxin Zorane |
|
| Definitions |
An oxazolidinone with centrally-acting skeletal muscle relaxant properties. Although the exact mechanism through which metaxalone exerts its effect is largely unknown, it might be due to general central nervous system (CNS) depression. Metaxalone has no direct effect on the contractile mechanisms of striated muscle, the motor end plate, or the nerve fiber. |
|
| ID |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C47606 |
|
| CAS_Registry |
1665-48-1 |
|
| Chemical_Formula |
C12H15NO3 |
|
| code |
C47606 |
|
| Concept_In_Subset | ||
| Contributing_Source |
FDA |
|
| DEFINITION |
An oxazolidinone with centrally-acting skeletal muscle relaxant properties. Although the exact mechanism through which metaxalone exerts its effect is largely unknown, it might be due to general central nervous system (CNS) depression. Metaxalone has no direct effect on the contractile mechanisms of striated muscle, the motor end plate, or the nerve fiber. |
|
| FDA_UNII_Code |
1NMA9J598Y |
|
| FULL_SYN |
2-Oxazolidinone, 5-((3,5-dimethylphenoxy)methyl)- METAXALONE Metaxalone Skelaxin Zorane |
|
| label |
Metaxalone |
|
| Legacy Concept Name |
Metaxalone |
|
| NSC Number |
170959 |
|
| Preferred_Name |
Metaxalone |
|
| prefixIRI |
Thesaurus:C47606 |
|
| Semantic_Type |
Pharmacologic Substance |
|
| UMLS_CUI |
C0163055 |
|
| subClassOf |